AU2018380582B2 - Feline calicivirus vaccine - Google Patents

Feline calicivirus vaccine

Info

Publication number
AU2018380582B2
AU2018380582B2 AU2018380582A AU2018380582A AU2018380582B2 AU 2018380582 B2 AU2018380582 B2 AU 2018380582B2 AU 2018380582 A AU2018380582 A AU 2018380582A AU 2018380582 A AU2018380582 A AU 2018380582A AU 2018380582 B2 AU2018380582 B2 AU 2018380582B2
Authority
AU
Australia
Prior art keywords
fcv
feline
vaccine
antigen
capsid protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018380582A
Other languages
English (en)
Other versions
AU2018380582A1 (en
Inventor
Ian Tarpey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of AU2018380582A1 publication Critical patent/AU2018380582A1/en
Priority to AU2025205386A priority Critical patent/AU2025205386A1/en
Application granted granted Critical
Publication of AU2018380582B2 publication Critical patent/AU2018380582B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2018380582A 2017-12-08 2018-11-05 Feline calicivirus vaccine Active AU2018380582B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025205386A AU2025205386A1 (en) 2017-12-08 2025-07-11 Feline calicivirus vaccine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762596508P 2017-12-08 2017-12-08
US62/596,508 2017-12-08
PCT/EP2018/080096 WO2019110213A1 (en) 2017-12-08 2018-11-05 Feline calicivirus vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025205386A Division AU2025205386A1 (en) 2017-12-08 2025-07-11 Feline calicivirus vaccine

Publications (2)

Publication Number Publication Date
AU2018380582A1 AU2018380582A1 (en) 2020-05-07
AU2018380582B2 true AU2018380582B2 (en) 2025-08-14

Family

ID=64316487

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018380582A Active AU2018380582B2 (en) 2017-12-08 2018-11-05 Feline calicivirus vaccine
AU2025205386A Pending AU2025205386A1 (en) 2017-12-08 2025-07-11 Feline calicivirus vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025205386A Pending AU2025205386A1 (en) 2017-12-08 2025-07-11 Feline calicivirus vaccine

Country Status (3)

Country Link
JP (3) JP7374893B2 (https=)
AU (2) AU2018380582B2 (https=)
WO (1) WO2019110213A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
WO2019115090A1 (en) * 2017-12-15 2019-06-20 Intervet International B.V. Multivalent feline vaccine
US11229699B2 (en) 2017-11-06 2022-01-25 Intervet Inc. Feline calicivirus vaccine
WO2021228731A1 (en) * 2020-05-11 2021-11-18 Intervet International B.V. Feline severe acute respiratory syndrome coronavirus 2 vaccine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US9441247B2 (en) * 2004-05-18 2016-09-13 Alphavax, Inc. TC-83-derived alphavirus vectors, particles and methods
WO2017109045A1 (en) * 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7309495B2 (en) 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
DK2947149T3 (en) 2007-06-21 2018-06-06 Alphavax Inc ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066568A2 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US9441247B2 (en) * 2004-05-18 2016-09-13 Alphavax, Inc. TC-83-derived alphavirus vectors, particles and methods
WO2017109045A1 (en) * 2015-12-23 2017-06-29 Intervet International B.V. Feline calicivirus vaccine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ATKINS GREGORY J ET AL, EXPERT REVIEWS IN MOLECULAR MEDI, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE, vol. 10, no. 1, 1 December 2008 (2008-12-01), pages e33/1 - 18, DOI: 10.1017/S1462399408000859 *
D. S. REED ET AL, JOURNAL OF VIROLOGY., vol. 88, no. 20, 13 August 2014 (2014-08-13), US, pages 12077 - 12086, DOI: 10.1128/JVI.01406-14 *
GUGLIELMO LUCCHESE ET AL, FRONTIERS IN BIOSCIENCE : ELITE EDITION, vol. 4, no. 5, 1 January 2012 (2012-01-01), pages 1843 - 1852, DOI: 10.2741/e506 *
LJUNGBERG KARL ET AL, EXPERT REVIEW OF VACC, EXPERT REVIEWS LTD, GB, vol. 14, no. 2, 1 February 2015 (2015-02-01), pages 177 - 194, DOI: 10.1586/14760584.2015.965690 *
VANDER VEEN RYAN L ET AL, ANIMAL HEALTH RESEARCH REV, CAB INTERNATIONAL ; CAMBRIDGE : CAMBRIDGE UNIVERSITY PRESS, UK, vol. 13, no. 1, 1 June 2012 (2012-06-01), pages 1 - 9, DOI: 10.1017/S1466252312000011 *
YASUSHI UEMATSU ET AL, CLINICAL AND VACCINE IMMUNOLOGY, vol. 19, no. 7, 23 May 2012 (2012-05-23), pages 991 - 998, DOI: 10.1128/CVI.00031-12 *

Also Published As

Publication number Publication date
JP2023159325A (ja) 2023-10-31
AU2018380582A1 (en) 2020-05-07
JP2025169275A (ja) 2025-11-12
JP7721604B2 (ja) 2025-08-12
JP7374893B2 (ja) 2023-11-07
WO2019110213A1 (en) 2019-06-13
JP2021505529A (ja) 2021-02-18
AU2025205386A1 (en) 2025-07-31

Similar Documents

Publication Publication Date Title
JP7721604B2 (ja) ネコカリシウイルスワクチン
AU2025230686A1 (en) Feline leukemia virus vaccine
US11992526B2 (en) Rabies virus vaccine
US20240398934A1 (en) Feline leukemia virus vaccine
CA3080087A1 (en) Multivalent feline vaccine
US11229699B2 (en) Feline calicivirus vaccine
RU2792898C2 (ru) Вакцина против кошачьего калицивируса
RU2797538C2 (ru) Поливалентная вакцина для животных семейства кошачьих
RU2784533C2 (ru) Вакцина против вируса лейкоза кошачьих
US20230355741A1 (en) Feline Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
US20240269259A1 (en) Rabies virus vaccine

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)